BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 16409469)

  • 1. Prerequisites for recombinant factor VIIa-induced thrombin generation in plasmas deficient in factors VIII, IX or XI.
    Livnat T; Zivelin A; Martinowitz U; Salomon O; Seligsohn U
    J Thromb Haemost; 2006 Jan; 4(1):192-200. PubMed ID: 16409469
    [TBL] [Abstract][Full Text] [Related]  

  • 2. General haemostatic agents--fact or fiction?
    Hedner U
    Pathophysiol Haemost Thromb; 2002; 32 Suppl 1():33-6. PubMed ID: 12214145
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of recombinant factor VIIa (FVIIa) in fibrin structure in the absence of FVIII/FIX.
    He S; Blombäck M; Jacobsson Ekman G; Hedner U
    J Thromb Haemost; 2003 Jun; 1(6):1215-9. PubMed ID: 12871322
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel therapeutic approach combining human plasma-derived Factors VIIa and X for haemophiliacs with inhibitors: evidence of a higher thrombin generation rate in vitro and more sustained haemostatic activity in vivo than obtained with Factor VIIa alone.
    Tomokiyo K; Nakatomi Y; Araki T; Teshima K; Nakano H; Nakagaki T; Miyamoto S; Funatsu A; Iwanaga S
    Vox Sang; 2003 Nov; 85(4):290-9. PubMed ID: 14633255
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thrombin generation and platelet activation induced by rFVIIa (NovoSeven) and NN1731 in a reconstituted cell-based model mimicking haemophilia conditions.
    Aljamali MN; Kjalke M; Hedner U; Ezban M; Tranholm M
    Haemophilia; 2009 Nov; 15(6):1318-26. PubMed ID: 19659796
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potential role of recombinant factor VIIa as a hemostatic agent.
    Hedner U; Erhardtsen E
    Clin Adv Hematol Oncol; 2003 Feb; 1(2):112-9. PubMed ID: 16224390
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Elevated factor VIII enhances thrombin generation in the presence of factor VIII-deficiency, factor XI-deficiency or fondaparinux.
    Szlam F; Sreeram G; Solomon C; Levy JH; Molinaro RJ; Tanaka KA
    Thromb Res; 2011 Feb; 127(2):135-40. PubMed ID: 21144556
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of recombinant factor VIIa on platelet function and clot structure in blood with deficient prothrombin conversion.
    Carr ME; Martin EJ; Kuhn JG; Seremetis SV
    Thromb Haemost; 2003 May; 89(5):803-11. PubMed ID: 12719776
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of platelets on fibrin gel structure formed in the presence of recombinant factor VIIa in hemophilia plasma and in plasma from a patient with Glanzmann thrombasthenia.
    He S; Ekman GJ; Hedner U
    J Thromb Haemost; 2005 Feb; 3(2):272-9. PubMed ID: 15670032
    [TBL] [Abstract][Full Text] [Related]  

  • 10. How factor VIIa works in hemophilia.
    Butenas S; Brummel KE; Bouchard BA; Mann KG
    J Thromb Haemost; 2003 Jun; 1(6):1158-60. PubMed ID: 12871314
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recombinant human factor VIIa (rFVIIa) can activate factor FIX on activated platelets.
    Gabriel DA; Li X; Monroe DM; Roberts HR
    J Thromb Haemost; 2004 Oct; 2(10):1816-22. PubMed ID: 15456494
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Does recombinant factor VIIa, apart from overall hemostasis, regulate TAFI dependent fibrinolysis? In vitro analysis using overall hemostasis potential (OHP) assay.
    Antovic JP; Antovic A
    Thromb Haemost; 2003 Oct; 90(4):620-7. PubMed ID: 14515182
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Factor VIII inhibitor-bypassing agents act by inducing thrombin generation and can be monitored by a thrombin generation assay.
    Turecek PL; Váradi K; Keil B; Negrier C; Berntorp E; Astermark J; Bordet JC; Morfini M; Linari S; Schwarz HP
    Pathophysiol Haemost Thromb; 2003; 33(1):16-22. PubMed ID: 12853708
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Whole blood clot formation phenotypes in hemophilia A and rare coagulation disorders. Patterns of response to recombinant factor VIIa.
    Sørensen B; Ingerslev J
    J Thromb Haemost; 2004 Jan; 2(1):102-10. PubMed ID: 14717973
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Emicizumab, the bispecific antibody to factors IX/IXa and X/Xa, potentiates coagulation function in factor XI-deficient plasma in vitro.
    Minami H; Nogami K; Yada K; Ogiwara K; Furukawa S; Soeda T; Kitazawa T; Shima M
    J Thromb Haemost; 2019 Jan; 17(1):126-137. PubMed ID: 30444568
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Platelet-dependent thrombin generation assay for monitoring the efficacy of recombinant Factor VIIa.
    Wegert W; Harder S; Bassus S; Kirchmaier CM
    Platelets; 2005 Feb; 16(1):45-50. PubMed ID: 15763896
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recombinant factor VIIa addition to haemophilic blood perfused over collagen/tissue factor can sufficiently bypass the factor IXa/VIIIa defect to rescue fibrin generation.
    Li R; Panckeri KA; Fogarty PF; Cuker A; Diamond SL
    Haemophilia; 2017 Sep; 23(5):759-768. PubMed ID: 28475272
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of factor VIIa and phospholipids on coagulation in "acquired" hemophilia.
    Butenas S; Brummel KE; Paradis SG; Mann KG
    Arterioscler Thromb Vasc Biol; 2003 Jan; 23(1):123-9. PubMed ID: 12524235
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacological concentrations of recombinant factor VIIa restore hemostasis independent of tissue factor in antibody-induced hemophilia mice.
    Keshava S; Sundaram J; Rajulapati A; Pendurthi UR; Rao LV
    J Thromb Haemost; 2016 Mar; 14(3):546-50. PubMed ID: 26727350
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhanced in vitro procoagulant and antifibrinolytic potential of superactive variants of recombinant factor VIIa in severe hemophilia A.
    Lisman T; de Groot PG; Lambert T; Røjkjaer R; Persson E
    J Thromb Haemost; 2003 Oct; 1(10):2175-8. PubMed ID: 14521601
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.